HomeTCRT • NASDAQ
add
Alaunos Therapeutics Inc
Previous close
$2.29
Day range
$2.23 - $2.39
Year range
$1.31 - $6.20
Market cap
5.07M USD
Avg Volume
241.45K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 854.00K | -13.74% |
Net income | -1.05M | 6.91% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.04M | 10.86% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.88M | 16.89% |
Total assets | 4.74M | 1.22% |
Total liabilities | 1.07M | 18.41% |
Total equity | 3.66M | — |
Shares outstanding | 2.19M | — |
Price to book | 1.30 | — |
Return on assets | -75.78% | — |
Return on capital | -110.09% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -1.05M | 6.91% |
Cash from operations | -701.00K | 58.30% |
Cash from investing | — | — |
Cash from financing | 3.26M | — |
Net change in cash | 2.56M | 252.29% |
Free cash flow | -564.38K | 56.00% |
About
Founded
1998
Website
Employees
1
